Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists-Reference-Cited by-同舟云学术

Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists

Published:2021-02-01 Issue:7 Volume:40 Page:2865-2871
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Suticen Erdem,Atas Nuh^ORCID,Guler Aslihan Avanoglu,Akdogan Orhun,Babaoğlu Hakan,Satis Hasan,Karadeniz Hazan,Haznedaroglu Seminur,Ozturk Mehmet Akif,Tufan Abdurrahman

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-021-05617-7.pdf

Reference28 articles.

1. Babaoglu H, Armagan B, Bodakci E, Satis H, Atas N, Sari A et al (2020) Predictors of persistent inflammation in familial Mediterranean fever and association with damage. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keaa378

2. Karadag O, Tufan A, Yazisiz V, Ureten K, Yilmaz S, Cinar M, Akdogan A, Erdem H, Ozturk MA, Pay S, Dinc A (2013) The factors considered as trigger for the attacks in patients with familial Mediterranean fever. Rheumatol Int 33(4):893–897. https://doi.org/10.1007/s00296-012-2453-x

3. Babaoglu H, Varan O, Atas N, Satis H, Salman R, Ozturk MA, Goker B, Haznedaroglu S, Tufan A (2019) Detection of familial Mediterranean fever attacks by using a connected activity tracker and assessment of impact of attacks to daily physical activities: a pilot study. Clin Rheumatol 38(7):1941–1946. https://doi.org/10.1007/s10067-019-04493-6

4. Atas N, Armagan B, Bodakci E, Satis H, Sari A, Bilge NSY, Salman RB, Yardımcı GK, Babaoglu H, Guler AA, Karadeniz H, Kilic L, Ozturk MA, Goker B, Haznedaroglu S, Kalyoncu U, Kasifoglu T, Tufan A (2020) Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study. Rheumatol Int 40(1):41–48. https://doi.org/10.1007/s00296-019-04412-7

5. Babaoglu H, Armagan B, Bodakci E, Satis H, Atas N, Sari A et al (2020) Factors associated with damage in patients with familial Mediterranean fever. Clin Exp Rheumatol

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy;International Immunopharmacology;2024-02

2. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome and Syndrome of Unexplained Recurrent Fevers in Children and Adults;The Journal of Allergy and Clinical Immunology: In Practice;2023-06

3. Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy;Journal of Market Access & Health Policy;2023-02-09

4. Factors affecting patient-acceptable symptom states and treatment decision in familial Mediterranean fever;Turkish Journal of Medical Sciences;2022-01-01

5. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment;Rheumatology International;2021-09-22